MorphImmune Inc. 13D and 13G filings for Immunome, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-07 08:39 am Purchase |
2023-06-29 | 13D | Immunome, Inc. IMNM |
MorphImmune Inc. | 2,659,508 20.000% |
2,659,508 (New Position) |
Filing |